You have searched for "US drug company"

Showing 51-60 of 222

Sort by: Newest | Oldest | Relevance

Business 25 May 2016 | 8:01 AM

Top foreign and local stories at 4pm

Top foreign and local stories at 4pm

Corporate News 25 May 2016 | 5:40 AM

Sanofi to unveil challenge to Medivation's board

New York: France's Sanofi SA is preparing to name candidates it will put forward to replace the entire board of US cancer drug company Medivation Inc as early as Wednesday, according to people familiar with the matter.

Corporate News 03 May 2016 | 1:45 AM

Ackman defends Valeant, hints at more changes

Boston: Billionaire investor William Ackman on Monday mounted a vigorous defense of Valeant Pharmaceuticals, ruling out any sale of the drug company's "crown jewel" assets but saying price cuts and even a new name may be in its future.

Business 03 May 2016 | 12:07 AM

Breakfast briefing: Tuesday, May 3

Breakfast briefing: Tuesday, May 3

Corporate News 07 Apr 2016 | 6:46 AM

Mega deals morph into mega problems for Wall Street

If 2015 was a dream year for Wall Street’s top dealmakers, 2016 is starting to take a nightmarish turn. The move by the Obama administration to suddenly change the rules has sent a chilling message to dealmakers and comes on top of a number of legal challenges to big transactions. The political uncertainty and antitrust concerns mean that firms will think twice about future tie-ups that consolidate industries and move tax dollars offshore.

Business 04 Apr 2016 | 10:46 PM

US regulator sues ValueAct over Halliburton-Baker Hughes disclosures

NEW YORK: The U.S. Department of Justice on Monday sued ValueAct Capital for violating notification requirements related to Halliburton Co's deal to buy rival Baker Hughes Inc, in a case that the activist hedge fund says it will fight

Viewpoints 04 Apr 2016 | 7:01 AM

Are you turning into a pill popper?

There seems to be a pill for every ill – and then some.

Corporate News 16 Mar 2016 | 12:27 AM

Valeant's stock rout serves up $5.3 billion in hedge fund losses

BOSTON: Hedge funds on Tuesday lost an estimated $5.3 billion on drugmaker Valeant Pharmaceuticals' stock meltdown, with billionaire investors William Ackman and Jeffrey Ubben taking the brunt of the hit - losing more than $700 million each, according to data from research firm Symmetric.IO.

World 16 Feb 2016 | 8:05 PM

Indian opposition raises concerns with Modi over student protests

NEW DELHI (Reuters) - Indian opposition leaders raised concerns on Tuesday with Prime Minister Narendra Modi over widening protests on university campuses, as the heated political atmosphere again threatened to stall reforms in parliament.

World 03 Feb 2016 | 1:41 AM

Scientists' path to usable Zika vaccine strewn with hurdles

LONDON (Reuters) - The world is once again asking scientists and drugmakers to come up rapidly with a vaccine for a viral disease that, in the latest case, few people had heard of until a few weeks ago, and even fewer feared.